New Company Fibrx Therapeutics Fights Scarring Disease
Skye Bioscience and Redx Pharma join forces to create Fibrx Therapeutics, a new company with $125 million to fight fibrosis.
Two strong drug companies, Skye Bioscience and Redx Pharma, now work together. They formed a new company called Fibrx Therapeutics. This new team will help people who suffer from a serious health problem called fibrosis. Fibrosis is when scar tissue grows too much inside the body. It can harm important organs.
Fibrx Therapeutics starts with a large sum of money. The company raised $125 million. This money will help them make new medicines. These medicines will stop or slow down scar tissue growth. Finding cures for fibrosis is a big goal.
This new company means hope for many patients. Fibrx Therapeutics plans to bring new treatments to market. They focus on helping those with scarring diseases. This important work could change lives for the better.
Source: FierceBiotech
More from Biotech
